ArticleClinical and translational science2026
Association of Three HIF-1α Genotypes With Susceptibility and Severity of Chronic Kidney Disease.
Article in Clinical and translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypoxic signaling is a critical factor in the pathogenesis of Chronic Kidney Disease (CKD). Hypoxia-Inducible Factor 1 (HIF-1) is a transcription factor that is highly expressed in the kidney and is associated with renal tubular hypoxic adaptation. Variation in the HIF-1α subunit gene has been associated with renal pathologies. This study investigated the association between three single-nucleotide polymorphisms (SNPs) in the HIF-1α gene: rs11549465 (P582S) in the Oxygen-Dependent Degradation Domain (ODDD), and two intronic SNPs, rs1957757, and rs1951795, with prevalence and severity of CKD. Primary genotypes were compared between 90 CKD patients (Stages II-V) and 48 healthy controls. Results revealed that the rs1951795 AA genotype was significantly more prevalent in the CKD group (30%) than in controls (5%) (p = 0.0017). Furthermore, specific genotypes correlated strongly with advanced disease stages: the P582S TT genotype was associated with an 18.07-fold increased adjusted odds of Stage IV CKD (p = 0.039), while the rs1957757 TT genotype carried an 11.16-fold increased odds of Stage V (p = 0.012). The rs1951795 AA genotype also showed an 8.33-fold increased odds for Stage V (p = 0.008). These findings suggest that variations in both the ODDD and intronic regions in the HIF-1α gene influence CKD susceptibility and progression. These SNPs may serve as important genetic markers for predicting the progression of CKD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.